NEW HAVEN, Conn., Aug. 19, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience ...
LAWRENCEVILLE, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (IMNN), a clinical-stage company in advanced development of its non-viral DNA-mediated immunotherapy, announces database lock for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results